Contributions of the epidermal growth factor receptor to keratinocyte motility

Microscopy Research and Technique

Volumn 43, Issue 5, 1998, Pages 444-455

  Hudson, Laurie G ^a   McCawley, Lisa J ^b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Epidermis; Growth factors; Invasion; Metastasis; Receptor tyrosine kinase; Wound healing

Indexed keywords

AMINO ACIDS; CELLS; TUMORS;

CELL MIGRATION; EPIDERMAL GROWTH FACTOR RECEPTORS; EPIDERMIS; GROWTH FACTOR; INVASION; KERATINOCYTES; METASTASIS; RECEPTOR-TYROSINE KINASE; TERMINAL DIFFERENTIATION; WOUND HEALING;

CELL ADHESION;

EPIDERMAL GROWTH FACTOR RECEPTOR;

CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL MOTILITY; CELL SURVIVAL; EPIDERMIS; HUMAN; KERATINOCYTE; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; WOUND HEALING;

EID: 0032387827     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0029(19981201)43:5<444::AID-JEMT10>3.0.CO;2-C     Document Type: Review

References (140)

1. Aaronson, S.A., Rubin, J.S. Finch, P.W., Wong, J., Marchese, C., Falco, J., Taylor, W.G., and Kraus, M.H. (1990) Growth factor-regulated pathways in epithelial cell proliferation. Am. Rev. Respir. Dis., 142:S7-10.
2. Alimandi, M., Wang, L.M., Bottaro, D., Lee, C.C., Kuo, A., Frankel, M., Fedi, P., Tang, C., Lippman, M., and Pierce, J.H. (1997) Epidermal growth factor and betacellulin mediate signal transduction through co-expressed erbB2 and erbB3 receptors. EMBO J., 16:5608-5617.
3. Anand-Apte, B., and Zetter B. (1997) Signaling mechanisms in growth factor-stimulated motility. Stem Cells, 15:259-67.
4. Ando, Y., and Jensen, P.J. (1993) Epidermal growth factor and insulin-like growth factor I enhance keratincoyte migration. J. Invest. Derm., 100:633-639.
5. Ando, Y., and Jenson, P.J. (1996) Protein kinase C mediates up regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro. J. Cell Phys., 167:500-511.
6. Andree, C., Swain, W.F., Page, C.P., Macklin, M.D., Slama, J., Hatzis, D., and Eriksson, E. (1994) In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc. Natl. Acad. Sci. U.S.A., 91:12188-12192.
7. Azuma, T., Witke, W., Stossel, T.P., Hartwig, J.H., and Kwiatkowski, D.J. (1998) Gelosin is a downstream effector of rac for fibroblast motility. EMBOJ., 17:1362-1370.
8. Barth, A.I., Nathke, I.S., and Nelson, W.J. (1997) Cadherins, catenins and APC protein: interplay between cytoskeleton complexes and signaling pathway. Curr. Opin. Cell Biol., 9:693-690.
9. Barrandon, Y., and Green, H.(1987) Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor-alpha and epidermal growth factor. Cell, 50:1131-1137.
10. Behrens, J., Vakaet, L., Friis, R., Winterhager, E., Van Roy, F., Mareel, M.M., and Birchmeier, W. (1993) Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β catenin complex in cells transformed with temperature sensitive v-src gene. J. Cell Biol., 120:757-766.
11. Beerli, R.R., and Hynes, N.E. (1996) Epidermal growth factor related peptides activate distinct subsets of erbB receptors and differ in their biological activities. J. Biol. Chem., 271:6071-6076.
12. Ben-Baruch, N., and Yarden, Y. (1994) Neu differentiation factors: A family of alternatively spliced neuronal and mesenchymal factors. Proc. Soc. Exp. Biol. Med., 206:221-227
13. Ben-Bassat, H., Rosenbaum-Mitrani, S., Hartzstark, Z., Shlomai, Z., Kleinberger-Doron, N., Gazit, A., Plowman, G., Levitzki, R., Tsvieli, R., and Levitzki, A. (1997) Inhibitors of epidermal growth factor receptor kinase and of cyclin dependent kinase 2 activation induce growth arrest, differentiation, and apoptosis of human papilloma virus 16-immortalized human keratinocytes. Cancer Res., 57:3741-3750.
14. Bhora, F.Y., Dunkin, B.J., Batzri, S., Aly, H.M., Bass, B.L., Sidawy, A.N., and Harmon, J.W. (1995) Effect of growth factors on cell proliferation and epithelialization in human skin. J. Surg. Res., 59:236-244.
15. Birchmeier, C., Meyer, D., and Riethmacher, D. (1995) Factors controlling growth, motility, and morphogenesis of normal and malignant epithelial cells. Int. Rev. Cytol., 160:221-266.
16. Boyd, D. (1996) Invasion and metastasis. Cancer Metast. Rev., 15:77-89.
17. Boyer, B., and Thiery, J. P. (1993). Epithelium-mesenchyme interconversion as example of epithelial plasticity. APMIS, 101:257-268.
18. Brown, G.L., Nanney, L.B., Griffin, J., et al. (1989) Enhancement of wound healing by topical treatment with epidermal growth factor. N. Engl. J. Med., 321:76-79.
19. Cardinali, M., Pietraszkiewicz, H., Ensley, J.F., and Robbins, K.C. (1995) Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies. Int. J. Cancer, 61:98-103.
20. Carpenter, G., and Cohen, S. (1979) Epidermal growth factor. Ann. Rev. Biochem., 48:193-216.
21. Carraway, K.L., and Cantley, L.C. (1994) A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell, 78:5-8.
22. Carraway, K.L., Weber, J.L., Unger, M.J., Ledesma, J., Yu, N., Gassmann, M., and Lai, C. (1997) Neuregulin-2, a new ligand of erbB3/erbB4-receptor tyrosine kinases. Nature, 387:512-516.
23. Cha, D., O'Brien, P., O'Toole, E., Woodley, D., and Hudson, L.G. (1996) Enhanced modulation of keratinocyte motility by transforming growth factor α (TGFα) relative to epidermal growth factor (EGF). J. Invest. Dermatol., 106:590-597.
24. Chapman, H.A. (1997) Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol., 9:714-724.
25. Chen, J.D., Kim, J.P., Zhang, K., Sarret, Y., Wynn, K.C., Kramer, R.H., and Woodley, D.T. (1993) Epidermal growth factor (EGF) promotes human keratinocyte locomotion on collagen by increasing the alpha 2 integrin subunit. Exp. Cell Res., 209:216-223.
26. Chen, C.S., Lavker, R.M., Rodeck, U., Risse, B., and Jensen, P.J. (1995) Use of a serum-free epidermal culture model to show deleterious effects of epidermal growth factor on morphogenesis and differentiation. J. Invest. Dermatol., 104:107-112.
27. Chen, P., Murphy-Ullrich, J., and Wells, A. (1996) A role for gelosin in actuating EGF receptor mediated cell motility. J. Cell Biol., 134:689-698.
28. Coffey, R.J., Derynck, R., Wilcox, J.N., Bringman, T.S., Goustin, A.S., Moses, H.L., and Pittelkow., M.R (1987) Production and auto-induction of transforming growth factor alpha in human keratinocytes. Nature, 328:817-820.
29. Cohen, B.D., Kiener, P.A., Green, J.M., Foy, L., Fell, H.P., and Zhang, K. (1996) The relationship between human epidermal growth-like factor expression and cellular transformation in NIH3T3 cells. J. Biol. Chem., 271:30897-30903.
30. Cook, P.W., Piepkorn, M., Clegg, C.H., Plowman, G.D., DeMay, J.M., Brown, J.R., and Pittelkow, M.R. (1997) Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J. Clin. Invest., 100:2286-2294.
31. Cowin, P., and Burke, B. (1996) Cytoskeleton-membrane interactions. Curr. Opin. Cell Biol., 8:56-65.
32. Credpaldi, T., Gautreau, A., Comoglio, P.M., Louvard, D., and Arpin, M. (1997) Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells. J. Cell Biol., 138:423-434
33. Danilenko, D.M., Ring, B.D., Lu, J.Z., Tarplay, J.E., Chang, D., Liu, N., Wen, D., and Pierce, G.F. (1995) Neu differentiation factor upregulates epidermal migration and integrin expression in excisional wounds. J. Clin. Invest., 95:842-851.
34. den Hartigh, J.C., van Bergen en Henegouwen P.M.P., Verkleij, A.J., and Boonstra, J. (1992) The EGF receptor is an actin binding protein. J. Cell Biol., 119:349-355.
35. Derynck R. (1990) Transforming growth factor-alpha. Mol. Reprod. Dev., 27:3-9.
36. DiGiovanni, J. (1995) Role of transforming growth factor-α and the epidermal growth factor receptor in multistage mouse skin carcinogenesis. In: Skin Cancer: Mechanisms and Human Relevance. H. Mukhtar, ed. CRC Press, Boaca Raton, pp. 181-197.
37. Dlugosz, A.A., Cheng, C., Williams, E.K., Darwiche, N., Dempsey, P.J., Mann, B., Dunn, A.R., Coffey, R.J. Jr., and Yuspa, S.H. (1995) Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: Potential involvement of alternate epidermal growth factor receptor ligands. Cancer Res., 55:1883-1893.
38. Dlugosz, A.A., Hansen, L., Cheng C., Alexander, N., Denning, M.F., Threadgill, D.W., Magnuson, T., Coffey, R.J. Jr., and Yuspa, S.H. (1997) Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras. Cancer Res., 57:3180-3188.
39. Dominey, A.M., Wang, X.J., King, L.E. Jr., Nanney, L.B., Gagne, T.A., Sellheyer, K., Bundman, D.S., Longley, M.A., Rothnagel, J.A., and Greenhalgh, D.A. et al. (1993) Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Differ., 4:1071-1082.
40. Downing, M.T., Brigstock, D.R., Luquette, M.H., Crissman-Combs, M., and Besner, G.E. (1997) Immunohistochemical localization of heparin-binding epidermal growth factor-like growth factor in normal skin and skin cancers. Histochem. J., 29:735-744.
41. Drozdoff, V., and Pledger, W.J. (1993) Commitment to differentiation and expression of early differentiation markers in murine keratinocytes in vitro are regulated independently of extracellular calcium concentrations. J. Cell Biol., 123:909-919.
42. Dunsmore, S.E., Rubin, J.S., Kovacs, S.O., Chedid, M., Parks, W.C., and Welgus, H.G. (1996) Mechanism of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. J. Biol. Chem., 271: 24576-24582.
43. Eccles, S.A., Modjtahedi, H., Box, G., Court, W., Sandle, J., and Dean, C.J. (1995) Significance of the c-erbB family of receptor tyrosine kinases in metastatic cancer and their potential as targets for immunotherapy. Invas. Metast, 14:337-348.
44. Edman, C.F., Prigent, S.A., Schipper, A., and Feramisco, J.R. (1997) Identification of ErbB3-stimulated genes using modified representational difference analysis. Biochem. J., 323:113-118.
45. Elenius, K., Paul, S., Allison, G., Sun, J., and Klagsbrun, M.(1997) Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J., 16:1268-1278.
46. Fujii, K. (1996) Ligand activation of overexpressed epidermal growth facator receptor results in loss of epithelial phenotype and impaired RGD-sensitive integrin function in HSC-1 cells. J. Invest. Dermatol., 107:195-202.
47. Fujii, K., Dousaka-Nakajima, N., and Imamura, S. (1995) Epidermal growth factor enhancement of HSC- 1 human cutaneous squamous carcinoma cell adhesion and migration on type I collagen involves selective upregulation of alpha 2 beta 1 integrin expression. Exp. Cell Res., 216:261-272.
48. Garnet, D.C., Pearson, G., Cerione, R.A., and Friedberg, I. (1997) Secondary dimerization between members of the epidermal growth factor receptor family. J. Biol. Chem., 272:12052-12056.
49. Garrod, D. R. (1993). Desmosomes and hemidesmosomes. Curr. Opin. Cell Biol., 5:30-40.
50. Gottlieb, A.B., Chang, C.K., Posnett, D.N., Fanelli, B., and Tam, J.P. (1988) Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes. J. Exp. Med., 167:670-675.
51. Grandis, J.R., and Tweardy, D.J. (1993a) Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res., 53:3579-3584.
52. Grandis, J.R., and Tweardy, D.J. (1993b) TGFα and EGFR in head and neck cancer. J. Cell. Biochem. Suppl. 17F:188-191.
53. Graus-Porta, D., Beerli, R.R., Daly, J.M., and Hynes, N.E. (1997) ErbB2, the preferred heterodimerization partner of all erbB receptors, is a mediator of lateral signaling. EMBO J., 16:1647-1655.
54. Green, K.J., and Stappenbeck, T.S. (1994). The desmosomal plaque: role in attachment of intermediate filaments to the cell surface. In: Molecular Mechanisms of Epithelial Junctions: From Development to Disease. S. Citi, ed. Austin, TX, R.G. Landes Co. pp 157-171.
55. Gronowski, A.M., and Bertics, P.J. (1995) Modulation of epidermal growth factor receptor interaction with detergent-insoluble cytoskeleton and its effects on receptor tyrosine kinase activity. Endocrinology, 136:2198-2205.
56. Gumbiner, B.M. (1996) Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell, 84:345-357.
57. Hall, A. (1994) Small GTP-binding proteins and the regulation of the actin cytoskeleton. Annu. Rev. Cell Biol., 10:31-54.
58. Hashimoto, K., Higashiyama, S., Asada, H., Hashimura, E., Kobayashi, T., Sudo, K., Nakagawa, T., Damm, D., Yoshikawa, K., and Taniguchi, N.(1994) Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J. Biol. Chem., 269:20060-20066.
59. Hazan, R.B., and Norton, L. (1998) The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton. J. Biol. Chem., 273:90778-90784.
60. Heldin CH. (1996) Protein tyrosine kinase receptors. Cancer Surv., 27:7-24.
61. Hoschuetzky, H., Aberle, H., and Kemler, R. (1994) Beta-catenin mediates the interaction of the cadherin -catenin complex with epidermal growth factor receptor. J. Cell Biol., 127:1375-1380.
62. Hudson, L.G., and Gill, G.N. (1991) Regulation of gene expression by epidermal growth factor. In: Genetic Engineering, Principles and Methods, Vol. 13. Plenum Press, New York, pp. 137-152.
63. Huang, G.C., Ouyang, X., and Epstein, R.J. (1998) Proxy activation of protein erbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction. Biochem. J., 331:113-119.
64. Jhappan, C., Takayama, H., Dickinson, R.B., and Merlino, G. (1994) Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways. Cell Growth Differentiation, 5:385-394.
65. Jenson, P.J., and Rodeck, U. (1993) Autocrine/paracrine regulation of keratinocyte urokinase plasminogen activator through the TGF-alpha/EGF receptor. J. Cell Physiol., 155:333-339
66. Jhappan, C., Takayama, H., Dickson, R.B., and Merlino, G.T. (1994) Cell Growth Differ., 5:385-394.
67. Ju, W.D., Schiller, J.T., Kazempour, M.K., and Lowry, D.R. (1993) TGFα enhances locomotion of cultured keratinocytes. J. Invest. Dermatol., 100:628-632.
68. Juarez, J., Clayman, G., Nakajima, M., Tanabe, K.K., Saya, H., Nicolson, G.L., and Boyd, D. (1993) Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous cell carcinoma cell lines of the oral cavity. Int. J. Cancer, 55:10-18.
69. Khazaie, K., Schirrmacher, V., and Lichtner R.B. (1993) EGF receptor in neoplasia and metastasis. Cancer Metast. Rev., 12:255-274.
70. King, L.E. Jr., Gates, R.E., Stoscheck, C.M., and Nanney, L.B. (1990) The EGF/TGF alpha receptor in skin. J. Invest. Dermatol., 94(Suppl): 164S-170S.
71. Kawamoto, T., Mendelsohn, J., Le, A., Sato, G.H., Lazar, C.S., and Gill, G.N. (1984) Relation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma A431 cells. J. Biol Chem., 259:7761-7766.
72. Lauffenburger, D.A., and Horwitz, A.F. (1996) Cell migration: A physically integrated molecular process. Cell, 84:359-369.
73. Lewis, J.E., Wahl, J.K. II, Sass, K.M., Jensen, P.J., Johnson, K.R., and Wheelock, M.J. (1997) Cross talk between adherens junctions and desmosomes depends on plakoglobin. J. Cell Biol., 136:919-934.
74. Lochter, A., Galosy, S., Muschler, J., Freedman, N., Werb, Z.., and Bissell, M.J. (1997) Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell. Biol., 139:1861-1872.
75. Lu, H., Mabilat, C., Yeh, P., Guitton, J.-D., Li, H., Pouchelet, M., Shoevaert, D., Legrand, Y., Soria, J. and Soria, C. (1996) Blockage of urokinase receptor reduces in vitro the motility and the deformability of endothelial cells. FEBS Lett., 380:21-24.
76. Lyons, J.G., Birkedal-Hansen, B., Pierson, M.C., Whitelock, J.M., and Birkedal-Hansen, H. (1993) Interleukin-1 beta and transforming growth factor-alpha/epidermal growth factor induce expression of Mr 95,000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes. J.Biol. Chem., 268: 19143-19151.
77. MacDougall, J.R., and Matrisian, L.M. (1995) Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metast. Rev., 14:351-362.
78. Mainiero, F., Pepe, A., Yeon, M., Ren, Y., an Giancotti, F. (1996) The intracellular functions of α6β4 integrin are regulated by EGF. J. Cell Biol., 134:241-253.
79. Marchese, C., Rubin, J., Ron, D., Faggioni, A., Torrisi, M.R., Messina, A., Frati, L., and Aaronson, S.A. (1990) Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J. Cell Physiol., 144:326-332.
80. Marikovsky, M., Breuing, K., Liu, P.Y., Eriksson, E., Higashiyama, S., Farber, P., Abraham, J., and Klagsbrun, M. (1993) Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc. Natl. Acad. Sci. U.S.A., 90:3889-3893.
81. Marikovsky, M., Lavi, S., Pinkas-Kramarski, R., Karunagran, D., Liu N., Wen, D., and Yarden, Y. (1995) ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes. Oncogene, 10:1403-1411.
82. Martin, P. (1997) Wound Healing: Aiming for perfect skin regeneration. Science, 276:75-81.
83. Matsumoto, K., Ziober, B.L., Yao, C.C., and Kramer, R.H. (1995) Growth factor regulation of integrin mediated motility. Cancer Metast. Rev., 14:205-217.
84. McCawley, L.J., O'Brien, P., and Hudson, L.G. (1997) Overexpression of the EGF receptor contributes to enhanced ligand-mediated motility in keratinocytes. Endocrinology, 138:1-7.
85. McCawley, L.J., Obrien, P., and Hudson, L.G. (1998) Epidermal growth factor (EGF) and scatter factor/hepatocyte growth factor (SF/HGF) mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)-9. J. Cell. Physiol., 176:255-265.
86. Miettinen, P.J., Berger, J.E., Meneses, J., Phung, Y., Pedersen, R.A., Werb, Z., and Derynck, R. (1995) Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature, 376:337-341.
87. Monzon, R., McWilliams, N., and Hudson, L.G. (1996) Suppression of cornified envelope formation and Type I transglutaminase by epidermal growth factor (EGF) in neoplastic keratinocytes Endocrinology, 137:1727-1734
88. Mitra, R.S., Wrone-Smith, T., Simonian, P., Foreman, K.E., Nunez, G., and Nickoloff, B.J. (1997) Apoptosis in keratinocytes is not dependent on induction of differentiation. Lab. Invest., 76:99-107.
89. Moroni, M.C., Willingham, M.C., and Beguinot, L (1992) EGF-R antisense RNA blocks expression of the epidermal growth factor receptor and suppresses the transforming phenotype of a human carcinoma cell line. J. Biol. Chem., 267:2714-2722.
90. Moulin, V. (1995) Growth factors in skin wound healing. Eur. J. Cell Biol., 68:1-7.
91. Nanney LB.(1990) Epidermal and dermal effects of epidermal growth factor during wound repair. J. Invest. Dermatol., 94:624-629.
92. Nanney, L.B., Magid, M., Stoscheck, C.M., and King, L.E. Jr. (1984) Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J. Invest. Dermatol., 83:385-393.
93. Nanney, L.B., Stoscheck, C.M., King, L.E. Jr., Underwood, R.A., and Holbrook, K.A. (1990) immunolocalization of epidermal growth factor receptors in normal developing human skin. J. Invest. Dermatol., 94:742-748.
94. Pena, J.C., Fuchs, E., and Thompson, C.B. (1997) Bcl-x expression influences keratinocyte survival but not terminal differentiation. Cell Growth Differ., 8:619-629.
95. Peus, D., Hamacher, L., and Pittelkow, M.R. (1997) EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation. J. Invest. Dermatol., 109:751-756.
96. Piepkorn, M., Lo, C., and Plowman, G. (1994) Amphiregulin-dependent proliferation of cultured human keratinocytes: autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycosaminoglycans. J. Cell. Physiol., 159:114-120.
97. Piepkorn, M., Underwood, R.A., Henneman, C., and Smith, L.T. (1995) Expression of amphiregulin is regulated in cultured human keratinocytes and in developing fetal skin. J. Invest. Dermatol., 105:802-809.
98. Pilcher, B.K., Dumin, J.A., Sudbeck, B.D., Krane, S.M., Welgus, H.G., and Parks, W.C. (1997) The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J. Cell Biol., 137:1445-1457.
99. Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Seger, R., Ratzkin, B.J., Sela, M., and Yarden, Y. (1996) Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J., 15:2452-2467.
100. Pinkas-Kramarski, R., Lenferink, A.E.G., Bacus, S.S., Lyass, L., van de Poll, M.L.M., Klapper, L.N., Tzahar, E., Sela, M., van Zoelen, E.J.J., and Yarden, Y. (1998) The oncogenic erbB-2/erbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin. Oncogene, 16:1249-1258.
101. Pittelkow, M.R., Cook, P.W., Shipley, G.D., Derynck, R., and Coffey, R.J. Jr. (1993) Autonomous growth of human keratinocytes requires epidermal growth factor receptor occupancy. Cell Growth Differ., 4:513-521.
102. Ponec, M., Gibbs, S., Weerheim, A., Kempenaar, J., Mulder, A., and Mommaas, A.M., (1997) Epidermal growth factor and temperature regulate keratinocyte differentiaiton. Arch. Dermatol. Res., 289:317-326.
103. Poumay, Y., and Pittelkow, M.R. (1995) Cell density and culture factors regulate keratinocyte commitment to differentiation and expression of suprabasal K1/K10 keratins. J. Invest. Dermatol., 104:271-276.
104. Riese, D.J. van Raaij, T.M, Plowman, G.D., Andrews, G.G., and Stern, D.F. (1995) The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol. Cell. Biol., 15:5770-5776.
105. Riese, D.J., Bermingham, Y., van Raaij, T.M, Buckley, S., Plowman, G.D., and Stern, D.F. (1996) Betacellulin activates the epidermal growth factor receptor and erbB4 and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene, 12:345-353.
106. Robinson, M.J., and Cobb, M.H. (1997) Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol., 9:180-186.
107. Rodeck, U., Jost, M., DuHadaway, J., Kari, C., Jensen, P.J., Risse, B., and Ewert, D.L. (1997a) Regulation of Bcl-xL expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor. Proc. Natl. Acad. Sci. U.S.A., 94:5067-5072
108. Rodeck, U., Jost, M., Kari, C., Shih, D.T., Lavker, R.M., Ewert, D.L., and Jensen, P.J. (1997b) EGF-R dependent regulation of keratinocyte survival. J. Cell Sci., 110:113-121.
109. Rømer, J., Bugge, T.H., Pyke, C., Lund, L.R., Flick, M.J., Degen, J.L., and Danø, K. (1996) Impaired wound healing in mice with dirupted plasminogen gene. Nature Med., 2:287-292.
110. Schaffer, C.J., and Nanney, L.B. (1996) Cell biology of wound healing. Int. Rev. Cytol., 169:151-181.
111. Schultz, G.S., White, M., Mitchell, R., Brown, G., Lynch, J., Twardzik, D.R., and Todaro, G.J. (1987) Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor. Science, 235:350-352.
112. Schultz G., Rotatori, D.S., and Clark, W. (1991) EGF and TGF-alpha in wound healing and repair. J. Cell. Biochem., 45:346-352.
113. Seedorf, K. (1995) Intracellular signaling by growth factors. Metabolism: Clinical and Experimental 44:24-32.
114. Shibamoto, S., Hayakawa, M., Takeuchi, K., Hori, T., Oku, N., Miyazawa, K., Kitamura, N., Takeichi, M., and Ito, F. (1994). Tyrosine phosphorylation of -catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adh. Commun., 1:295-305.
115. Sibilia, M., and Wagner, E.F.(1995) Strain-dependent epithelial defects in mice lacking the EGF receptor. Science, 269:234-238.
116. Solic, N., and Davies, D.E. (1997) Differential effects of EGF and amphiregulin on adhesion molecule expression and migration on colon carcinoma cells. Exp. Cell Res., 234:465-476.
117. Stafansson, S., and Lawrence, D. A. (1996) The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin. Nature, 383:441-443.
118. Stetler-Stevenson, W.G., Aznavoorian, S., and Liotta, L.A. (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann. Rev. Cell Biol. 9:541-573.
119. Stoscheck, C.M., Nanney, L.B., and King, L.E. Jr. (1992) Quantitative determination of EGF-R during epidermal wound healing. J. Invest. Dermatol., 99:645-649.
120. Stoll, S., Garner, W., and Elder, J. (1997) Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation in skin organ culture. J. Clin. Invest., 100:1271-1281.
121. Stoll, S.W., Benedict, M., Mitra, R., Hiniker, A., Elder, J.T., and Nunez, G. (1998) EGF receptor signaling inhibits keratinocyte apoptosis: evidence for mediation by Bel-XL. Oncogene, 16:1493-1499.
122. Thiery, J.P., and Boyer, B. (1992) The junction between cytokincs and cell adhesion. Curr. Op. Cell Biol., 4:782-792.
123. Threadgill, D.W., Dlugoz, A.a., Hansen, L.A., Tennenbaum, T., Lichti, U., Yee, D., LaMant, C., Mourton, T., Herrup, K., Harris, R.C., Barnard, J.A., Yuspa, S.H., Coffey, R.J., and Magnuson, T. (1995) Targeted disruption of mouse EOF receptor: Effect of genetic background on mutant phenotype. Science, 269:230-234.
124. Tsukita, S., Yonemura, S., and Tsukita, S. (1997) ERM (ezrin/radixin/ moesin) family: from cytoskeleton to signal transduction. Curr. Opin. Cell Biol., 9:70-75.
125. Tzahar, E., andYarden, Y (1998) The ErbB-1/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands. Biochim. Biophys. Acta, 1377:M25-M37.
126. van der Geer, P., Hunter, T., and Lindberg, R.A. (1994) Receptor protein tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol., 10:251-337.
127. van der Heyden, M.A., Van Bergen en Henegouwen, P.M., de Ruiter, N., Verdaasdonk, M.A., van den Tweel, J.G., Rijksen, G., Boonstra, J., and Joling, P. (1997) the actin binding domain of the epidermal growth factor receptor is required for EGF-stimulated tissue invasion. Exp. Cell Res., 234:521-526.
128. Vassar, R., and Fuchs, E. (1991) Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes Dev., 5:714-727.
129. Vassar, R., Hutton, M.E., and Fuchs, E. (1992) Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis. Mol. Cell. Biol., 12:4643-4653.
130. Wang, X.J., Greenhalgh, D.A., Eckhardt, J.M., Rothnagel, J.A., and Roop, D.R. (1994) Epidermal expression of transforming growth factor-alpha in transgenic mice: induction of spontaneous and 12-O-tetradecanoylphorbol-13-acetate-induced papillomas via a mechanism independent of Ha-ras activation or overexpression. Mol. Carcinogen., 10:15-22.
131. Wang, X.J., Greenhalgh, D.A., Lu, X.R., Bickenbach, J.R., and Roop, D.R. (1995) TGFα and v-fos cooperation in transgenic mouse epidermis induces aberrant keratinocyte differentiation and stable, autonomous papillomas. Oncogene, 10:279-289.
132. Watabe, M., Matsumoto, K., Nakamura, T., and Takeichi, M. (1993). Effect of hepatocyte growth factor on cadherin-mediated cell-cell adhesion. Cell Struct. Funct., 18:117-124.
133. Weichselbaum, R.R., Dunphy, E.J., Beckett, M.A., Tybor, A.G., Moran, W.J., Goldman, M.E., Yokes, E.E., and Panje, W.R. (1989) Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines. Head Neck, 11:437-442.
134. Wenczak, B.A., Lynch, J.B., and Nanney, L.B. (1992) Epidermal growth factor receptor distribution in burn wounds. Implications for growth factor-mediated repair. J. Clin. Invest., 90:2392-2401.
135. Werb, Z. (1997) ECM and cell surface proteolysis: Regulating cellular ecology. Cell 91:439-442
136. Winkles, J.A. (1998) Serum- and polypeptide growth factor-inducible gene expression in mouse fibroblasts. Prog. Nucleic Acid Res. Mol. Biol., 58:41-78.
137. Yates, R.A., Nanney, L.B., Gates, R.E., and King, L.E. Jr (1991) Epidermal growth factor and related growth factors. Int. J. Dermatol., 30:687-694.
138. Yamada, K.M., and Geiger, B. (1997) Molecular interactions in cell adhesion complexes. Curr. Opin. Cell Biol., 9:76-85.
139. Yebra, M., Parry, G.C.N., Strömblad, S., Mackman, N., Rosenberg, S., Mueller, B.M., and Cheresh, D.A. (1996) Requirement of receptor-bound urokinase-type plaminogen activator for integrin αvβ5-directed cell migration. J. Biol. Chem., 271:29393-29399.
140. Zhang, K, Sun, J., Liu, N., Wen, D., Chang, D., Thomason, A., and Yoshinaga, S.K. (1996) Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J. Biol. Chem., 271:3884-3890.